KELLEIGH SORENSON: Open Payments
NPI 1376282178 · PASO ROBLES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$745 in 28 payments from 9 companies in 2025. Trend: 2023 $357 · 2024 $0 · 2025 $745
Food & beverage: $645Education: $100
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 10 | $219 |
| ABBVIE INC. | 5 | $151 |
| Astellas Pharma US Inc | 2 | $129 |
| Novo Nordisk Inc | 4 | $86 |
| PFIZER INC. | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
| Lilly USA, LLC | 1 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Exact Sciences Corporation | 1 | $19 |
Products named: TRELEGY ELLIPTA, UBRELVY, AREXVY, QULIPTA, Ozempic, JARDIANCE, Veozah, MOUNJARO.
Industry payments across CA — which companies pay providers there.
